FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2135708745> ?p ?o ?g. }

• W2135708745 abstract "CO RR EC TE D P RO OF 1.5%; all events were non-serious, mild, and did not result in dose reduction or discontinuation. Three were considered possibly related to eliglustat by the treating physician. Combined incidence of PN (n = 8) and polyneuropathy (n = 1) was 2.3%. No event was serious; most (7/9) were assessed as unrelated to eliglustat. All events of tremor and PN occurred only once in each patient; none resulted in eliglustat discontinuation or dose decrease. Six PN events occurred within 18 months of eliglustat initiation. Excluding the underlying Gaucher disease (itself a known cause of PN), review of the medical history showed that the vast majority of patients had additional risk factors for developing neurological symptoms or medical conditions associated with neuropathy including: hypothyroidism, Hashimoto's thyroiditis, diabetes mellitus, vitamin B12 deficiency, and monoclonal gammopathy. Most patients with PN had normal neurologic exams, non-progression of symptoms despite continuation of drug, anatomic locations inconsistent with druginduced neuropathy, and lack of supportive NCV findings. In the four patients reporting adverse events of PN in the ENCORE trial, three had NCV results available at baseline and 12 months; none had changes from baseline or findings of clinical significance on neurologic exams supporting a causal role of eliglustat. Notably, the patient who experienced both PN and paraesthesia had decompensated diabetes, hypothyroidism, and a history of paraesthesia. Evidence from the eliglustat safety database supports the claim that eliglustat does not promote tremor (1 event/100 person-years) or PN. The rate of PN adverse events noted after eliglustat treatment (2 events/100 person-years) is well within the rate of neuropathy that might be expected to develop spontaneously in the GD1 population (2.9 events/100 person-years); both rates are higher than that of the general population (between 0.0046 and 0.015/100 person-years) recently reported by Biegstraaten et al. (Brain 2010:133;2909)." @default.
• W2135708745 created "2016-06-24" @default.
• W2135708745 creator A5016812185 @default.
• W2135708745 creator A5030738571 @default.
• W2135708745 creator A5033041462 @default.
• W2135708745 creator A5052852055 @default.
• W2135708745 creator A5061624296 @default.
• W2135708745 date "2015-02-01" @default.
• W2135708745 modified "2023-10-17" @default.
• W2135708745 title "Pedigree analysis in patients with Fabry disease: Evaluating changes in referral and diagnosis over successive generations" @default.
• W2135708745 doi "https://doi.org/10.1016/j.ymgme.2014.12.150" @default.
• W2135708745 hasPublicationYear "2015" @default.
• W2135708745 type Work @default.
• W2135708745 sameAs 2135708745 @default.
• W2135708745 citedByCount "0" @default.
• W2135708745 crossrefType "journal-article" @default.
• W2135708745 hasAuthorship W2135708745A5016812185 @default.
• W2135708745 hasAuthorship W2135708745A5030738571 @default.
• W2135708745 hasAuthorship W2135708745A5033041462 @default.
• W2135708745 hasAuthorship W2135708745A5052852055 @default.
• W2135708745 hasAuthorship W2135708745A5061624296 @default.
• W2135708745 hasConcept C126322002 @default.
• W2135708745 hasConcept C187212893 @default.
• W2135708745 hasConcept C197934379 @default.
• W2135708745 hasConcept C2778715236 @default.
• W2135708745 hasConcept C2779134260 @default.
• W2135708745 hasConcept C71924100 @default.
• W2135708745 hasConceptScore W2135708745C126322002 @default.
• W2135708745 hasConceptScore W2135708745C187212893 @default.
• W2135708745 hasConceptScore W2135708745C197934379 @default.
• W2135708745 hasConceptScore W2135708745C2778715236 @default.
• W2135708745 hasConceptScore W2135708745C2779134260 @default.
• W2135708745 hasConceptScore W2135708745C71924100 @default.
• W2135708745 hasLocation W21357087451 @default.
• W2135708745 hasOpenAccess W2135708745 @default.
• W2135708745 hasPrimaryLocation W21357087451 @default.
• W2135708745 hasRelatedWork W145829892 @default.
• W2135708745 hasRelatedWork W1731209403 @default.
• W2135708745 hasRelatedWork W194759439 @default.
• W2135708745 hasRelatedWork W1975897800 @default.
• W2135708745 hasRelatedWork W2065394317 @default.
• W2135708745 hasRelatedWork W2074405678 @default.
• W2135708745 hasRelatedWork W2322286659 @default.
• W2135708745 hasRelatedWork W2328110346 @default.
• W2135708745 hasRelatedWork W2557315216 @default.
• W2135708745 hasRelatedWork W2964201019 @default.
• W2135708745 hasRelatedWork W2967278608 @default.
• W2135708745 hasRelatedWork W2981593013 @default.
• W2135708745 hasRelatedWork W3014258435 @default.
• W2135708745 hasRelatedWork W3015068610 @default.
• W2135708745 hasRelatedWork W3034456041 @default.
• W2135708745 hasRelatedWork W3043135994 @default.
• W2135708745 hasRelatedWork W3098814026 @default.
• W2135708745 hasRelatedWork W3201065198 @default.
• W2135708745 hasRelatedWork W3211699139 @default.
• W2135708745 hasRelatedWork W420382016 @default.
• W2135708745 isParatext "false" @default.
• W2135708745 isRetracted "false" @default.
• W2135708745 magId "2135708745" @default.
• W2135708745 workType "article" @default.